Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Trial of Coartemether and Artekin for the Treatment of Uncomplicated Malaria in Papua, Indonesia.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female patients at least one 1year of age and weighing more than 10kg.~* Microscopic confirmation of P. falciparum and /or P.vivax infection (any parasitaemia).~* Fever (axillary temperature \>37.5C) or history of fever in the last 48 hours.~* Able to participate in the trial and comply with the clinical trial protocol~* Written informed consent to participate in trial; verbal consent in presence of literate witness is required for illiterate patients, and written consent from parents/guardian for children below age of consent~Exclusion Criteria:~* Pregnancy or lactation~* Inability to tolerate oral treatment~* Signs/symptoms indicative of severe/complicated malaria or warning signs requiring parenteral treatment (See Appendix II)~* Known hypersensitivity or allergy to artemisinin derivatives~* Serious underlying disease (cardiac, renal or hepatic)~* Parasitaemia \>4%

- Gender: ALL
- Minimum Age: 12 Months
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).